{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:36:02Z","timestamp":1763534162214,"version":"3.37.3"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012655","name":"Qilu Hospital of Shandong University","doi-asserted-by":"crossref","award":["QDKY2019QN12"],"award-info":[{"award-number":["QDKY2019QN12"]}],"id":[{"id":"10.13039\/100012655","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Pilot studies have reported that patients with systemic lupus erythematosus (SLE) appear more likely to develop into neoplasia, especially lymphatic hyperplasia diseases. To our knowledge, this is the first case report of the concomitant onset of SLE and primary breast diffuse large B-cell lymphoma (PB-DLBCL).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We reported an unusual case of the occurrence of primary breast diffuse large B-cell lymphoma in a 25-year-old female patient who had been diagnosed with SLE and treated with immunosuppressive drugs for about 4 years. She presented a 7-week history of a painless mass above the left breast and no history suggestive of any nipple discharge, fever, and weight loss.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Ultrasonography of the breast showed that there was 1 mass in the left breast. After breast mass surgical resection, histopathological examinations were performed and revealed that it was primary breast diffuse large B-cell lymphoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Treatment strategy with vincristine and dexamethasone was used to improve symptoms. However, the patient's renal function deteriorated and the blood potassium rose continuously and she and their family members refused the follow-up treatments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient died 8 months after she was discharged from the hospital.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>PB-DLBCL is a rare occurrence in SLE patients. Therefore, a careful examination is very important in SLE cohort, as activity of the disease and malignancy may mimic each other. Meanwhile, when symptoms cannot be explained or insensitive to treatment, the occurrence of malignant tumors must be highly considered.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000021736","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T06:06:13Z","timestamp":1597298773000},"page":"e21736","source":"Crossref","is-referenced-by-count":5,"title":["Primary breast diffuse large B-cell lymphoma in a patient with systemic lupus erythematosus"],"prefix":"10.1097","volume":"99","author":[{"given":"Feifei","family":"Shen","sequence":"first","affiliation":[{"name":"Department of Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, Shandong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifeng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shupeng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengjie","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Luohu District People's Hospital, Shenzhen, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.arcmed.2015.09.005","article-title":"Plasma\/serum leptin levels in patients with systemic lupus erythematosus: a meta-analysis","volume":"46","author":"Li","year":"2015","journal-title":"Arch Med Res"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/art.21029","article-title":"An international cohort study of cancer in systemic lupus erythematosus","volume":"52","author":"Bernatsky","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jnci\/djj004","article-title":"Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype","volume":"98","author":"Smedby","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of lymphoma development in autoimmune diseases: a meta-analysis","volume":"165","author":"Zintzaras","year":"2005","journal-title":"Arch Intern Med"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1136\/ard.2004.034504","article-title":"Non-Hodgkin's lymphoma in systemic lupus erythematosus","volume":"64","author":"Bernatsky","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.rdc.2005.01.002","article-title":"Exploring the links between systemic lupus erythematosus and cancer","volume":"31","author":"Bernatsky","year":"2005","journal-title":"Rheum Dis Clin North Am"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1191\/096120301678646128","article-title":"Systemic lupus erythematosus and the risk of malignancy","volume":"10","author":"Cibere","year":"2001","journal-title":"Lupus"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/art.1780400424","article-title":"Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus","volume":"40","author":"Mellemkjaer","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ctrv.2014.05.010","article-title":"Primary breast lymphoma","volume":"40","author":"Cheah","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clbc.2012.07.006","article-title":"Treatment and outcomes of primary breast lymphoma","volume":"12","author":"Caon","year":"2012","journal-title":"Clin Breast Cancer"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1093\/annonc\/mdt192","article-title":"Primary diffuse large b-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options","volume":"24","author":"Aviv","year":"2013","journal-title":"Ann Oncol"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/PAS.0b013e318165eb50","article-title":"Lymphomas involving the breast: a study of 106 cases comparing localized and disseminated neoplasms","volume":"32","author":"Talwalkar","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1080\/10428194.2018.1460825","article-title":"Primary breast diffuse large b-cell lymphoma: treatment strategies and patterns of failure","volume":"59","author":"Ludmir","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/annonc\/mdm587","article-title":"Diffuse large b-cell lymphoma of the breast: a distinct entity?","volume":"19","author":"Bierman","year":"2008","journal-title":"Ann Oncol"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/annonc\/mdn379","article-title":"Breast lymphoma","volume":"19","author":"Aviles","year":"2008","journal-title":"Ann Oncol"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaut.2012.12.009","article-title":"Cancer risk in systemic lupus: an updated international multi-centre cohort study","volume":"42","author":"Bernatsky","year":"2013","journal-title":"J Autoimmun"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.smim.2006.04.004","article-title":"BAFF, APRIL and human B cell disorders","volume":"18","author":"Tangye","year":"2006","journal-title":"Semin Immunol"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.3899\/jrheum.101190","article-title":"Expression of APRIL in diffuse large B cell lymphomas from patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"38","author":"Lofstrom","year":"2011","journal-title":"J Rheumatol"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s10067-006-0532-7","article-title":"Characteristics of patients with systemic lupus erythematosus (SLE) and non-Hodgkin's lymphoma (NHL)","volume":"26","author":"King","year":"2007","journal-title":"Clin Rheumatol"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/annrheumdis-2012-202099","article-title":"Lymphoma risk in systemic lupus: effects of disease activity versus treatment","volume":"73","author":"Bernatsky","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1177\/0961203311412413","article-title":"Brain diffuse large B-cell lymphoma in a systemic lupus erythematosus patient treated with immunosuppressive agents including mycophenolate mofetil","volume":"20","author":"Svobodova","year":"2011","journal-title":"Lupus"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/BOR.0000000000000202","article-title":"Malignancies in systemic lupus erythematosus: a 2015 update","volume":"27","author":"Goobie","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"R23-20230915","first-page":"1478","article-title":"Risk of malignancy in women with systemic lupus erythematosus","volume":"22","author":"Sweeney","year":"1995","journal-title":"J Rheumatol"},{"key":"R24-20230915","first-page":"S91","article-title":"Risk of malignancy in cyclophospamide-treated SLE patients","volume":"36","author":"Pryol","year":"1993","journal-title":"Arthritis Rheum"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/ard.51.4.437","article-title":"Increased risk of cancer in patients with systemic lupus erythematosus","volume":"51","author":"Pettersson","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0049-0172(88)90001-7","article-title":"Cancer in autoimmune diseases","volume":"18","author":"Sela","year":"1988","journal-title":"Semin Arthritis Rheum"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3324\/haematol.2008.001495","article-title":"Molecular pathogenesis of follicular lymphoma","volume":"93","author":"Ott","year":"2008","journal-title":"Haematologica"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1196\/annals.1422.008","article-title":"Occurrence of malignancies in Hungarian patients with systemic lupus erythematosus: results from a single center","volume":"1108","author":"Tarr","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R29-20230915","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1191\/0961203302lu182rr","article-title":"Systemic lupus erythematosus and cancer: associated or not?","volume":"11","author":"Abu-Shakra","year":"2002","journal-title":"Lupus"},{"key":"R30-20230915","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1172\/JCI119856","article-title":"An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus","volume":"100","author":"James","year":"1997","journal-title":"J Clin Invest"},{"key":"R31-20230915","first-page":"535738","article-title":"Epstein-Barr virus in systemic autoimmune diseases","author":"Draborg","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"R32-20230915","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nrrheum.2011.62","article-title":"Susceptibility of patients with rheumatic diseases to b-cell non-Hodgkin lymphoma","volume":"7","author":"Dias","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"R33-20230915","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","article-title":"Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the international lymphoma radiation oncology group","volume":"92","author":"Yahalom","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R34-20230915","first-page":"109","article-title":"Primary breast lymphoma in the United States: 1975-2013","author":"Thomas","year":"2017","journal-title":"J Natl Cancer Inst"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021736","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T01:15:20Z","timestamp":1694826920000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021736"}},"subtitle":["A case report and review of the literature"],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":34,"journal-issue":{"issue":"33","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000021736","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2020,8,14]]}}}